GOCOVRI 68.5 mg/1

GOCOVRI 68.5 mg/1 is a coated pellet capsule containing amantadine, used for managing certain movement disorders. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals in the USA.

GOCOVRI 68.5 mg/1 is primarily used to manage symptoms associated with movement disorders. Amantadine, the active ingredient, is often prescribed to help control involuntary movements and improve mobility. This medication is designed to provide relief from symptoms that can interfere with daily activities.

Common effects of GOCOVRI 68.5 mg/1 may include dizziness, dry mouth, and nausea. Some users may experience changes in vision or swelling in the legs. These effects can vary from person to person and may not affect everyone who takes the medication.

GOCOVRI 68.5 mg/1 should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

GOCOVRI 68.5 mg/1 may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.